Key facts
- It has raised $25.9M; the latest was Later Stage VC ($3.1M) in Mar 2025.
- Notable investors include LIFTT, ABC Company.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Lipogems
- ·The full record, as it builds
Funding rounds
No funding rounds for Lipogems are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lipogems
Developer of effective medical technologies designed to offer a compliant and reliable option for orthopedic issues. The company's system provides cushion and assistance for the healing process that contains a high concentration of reparative cells, does not decline with age and processing preserves the cell and tissue microarchitecture, enabling orthopedic physicians and scientists to reduce the risk of contamination through a simple and minimally invasive procedure.
- Sector
- Healthcare
- HQ
- Milan, Italy
- Founded
- 2010
- Employees
- 21
- Website
- lipogems.com/
- Ownership
- Privately Held (backing)
Lipogems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lipogems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lipogems in its N-PORT filings yet. We sweep new filings monthly.